TrialHealth technology assessment (Winchester, England)2023

A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.

Sube Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.